NCT05492591View on ClinicalTrials.gov

A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 11, 2022

Primary Completion Date

July 22, 2023

Study Completion Date

July 22, 2023

Conditions
Herpes Zoster
Interventions
DRUG

Peginterferon α1b

Injecting different doses of the peginterferon α1b into different groups of subjects.

DRUG

Peginterferon α1b with valacyclovir

Both valacyclovir tablets and different dose of peginterferon α1b plan to be used in different groups of subjects.

DRUG

Valacyclovir

Valacyclovir is a positive control drug.

Trial Locations (1)

Unknown

Chinese Academy of Medical Sciences Dermatology Hospital, Nanjing

All Listed Sponsors
lead

Shanghai Institute Of Biological Products

INDUSTRY